Copyright © Inderes 2011 - present. All rights reserved.

Acarix

0.27 SEK

+4.03 %

Less than 1K followers

ACARIX

First North Stockholm

Medical Equipment & Services

Health Care

+4.03 %
+8.40 %
+1.12 %
-12.30 %
-5.57 %
+28.13 %
-48.86 %
-72.10 %
-96.33 %

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Read more
Market cap
336.19M SEK
Turnover
565.43K SEK
Revenue
7.36M
EBIT %
-652.31 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7/5
2026

Interim report Q1'26

13/5
2026

General meeting '26

13/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
On my journey in search of a new Revenio, in a country where vague Finland-Swedish was spoken and which was ruled by Carl XVI Gustaf, I came across a company called Acarix. And I’m not comparing this to be a new Revenio. For the diagnosis of coronary artery disease, a common basic...
9/8/2021, 5:11 AM
by Fisu
9
Odotettu 79 MSEK osakeanti nyt käynnissä: acarix.com Acarix | CADScor®System
12/6/2021, 12:06 AM
by Pohjolan Eka
3
Tärkeimmät talousuutiset | Kauppalehti Acarix CADScor®System included in NICE guidelines (UK) Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä. Tuossa hieman vanhempaa tiedotetta. Mielenkiintoinen tuote, joka on tutkimuksissa...
9/8/2021, 7:32 AM
by PP2020
3
Mielenkiintoista, että analyytikkofirma on myös neuvonantajana… Onkohan sijoittajana myös.?
9/8/2021, 5:33 AM
by Yoda
3
Redeye:n sivuilta kyllä ko. Yhtiön kohdalta löytyy Disclosures joka kertoo omistaako Redeye yhtiötä. Tässä tapauksessa ei omista. redeye.se Acarix Disclosures - Redeye Discover the latest equity research on Acarix.
9/8/2021, 2:45 PM
by Llopardi
2
PubMed Economic Analysis of the CADScor System for Ruling Out Coronary Artery... The CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the...
9/8/2021, 5:40 AM
by PP2020
2
Uutista Amerikan mailta on tullut, en osaa sitä tänne siirtää. Kiitos jo etukäteen
10/27/2021, 11:02 AM
by Hollitupa
1
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.